Progress against tuberculosis has long been inadequate to reach the target of elimination by 2030. But before the COVID-19 pandemic the world was making steady progress in diagnosing and treating TB.
Articles on Tuberculosis (TB)
Displaying 61 - 80 of 193 articles
Countries must be encouraged to distribute essential healthcare provision - like diagnosis - to where people most need them and where they can be accessed more easily.
Smallpox, tuberculosis, measles, syphilis … a new book describes how recurring epidemics nearly wiped out Australia’s First Peoples.
COVID has shown us we can develop a range of safe and effective vaccines. Now we need to do the same for TB.
BCG remains the only widely available vaccine for TB. Yet the development of a COVID-19 vaccine over the last year shows that there is capacity to rapidly create new vaccines.
South Africa needs a public health response that expands the successes of the country’s HIV testing and treatment programme to provide care for multiple diseases.
Not achieving the targets for children and adolescents in sub-Saharan Africa means that new infections will continue to increase and HIV related mortality will be a reality for decades to come.
She believed and advocated that Africa needs to find solutions to its own problems and worked tirelessly to build biomedical engineering capacity across the continent.
The key actions needed to end AIDS are relatively clear. The question is whether every government, funder, and implementing organisations will apply them.
Until vaccines that are capable of protecting all populations against TB are developed, treatment is the best option to preventing infection.
An out-of-control COVID epidemic in PNG would be a humanitarian and economic disaster for the nation itself, and a grave threat to the region.
South Africa’s long-awaited TB prevalence survey results were recently released. They reveal that the country has a much higher burden of TB than previously thought.
Where there are not enough health workers to deliver medical care, one solution is to move certain tasks to less specialised health workers, a process called task-shifting.
Doubt can be uncomfortable. It is often tempting to jump to conclusions. But Keats counsels otherwise.
Tuberculosis is a global threat and a public health concern on a scale similar to COVID-19.
One of the main challenges remains that diagnostics and drugs for people suffering from advanced HIV aren’t readily available. This group of people is vulnerable to deadly opportunistic infections.
A COVID-19 vaccine isn’t the only tool for fighting this pandemic. An immunologist argues that safe pneumonia vaccines would reduce the severity of COVID-19, save lives and prevent the worst cases.
As ready as you are to be done with COVID-19, it’s not going anywhere soon. A historian of disease describes how once a pathogen emerges, it’s usually here to stay.
Our first exposure to a pathogen, either naturally or via vaccination, can affect how our immune system responds in the future to the same or similar pathogens.
Some insights into previous outbreaks of human coronaviruses may be useful in explaining the comparatively ‘low’ numbers of COVID-19 infections and mortality in people with HIV in South Africa.
Top contributors
-
Canada Research Chair of Epidemiology & Global Health, McGill University
-
Assistant Professor, Africa Health Research Institute (AHRI)
-
Head of the Centre of Excellence for Biomedical TB Research, University of the Witwatersrand
-
Deputy Director of the Centre for Tuberculosis Research, Reader in Tuberculosis and Social Medicine, Liverpool School of Tropical Medicine, Liverpool, UK; and Honorary Research Associate at Karolinska Institutet, Stockholm, Sweden, and, University of Liverpool
-
Faculty Member, Africa Health Research Institute; Associate professor, UCL
-
Associate Professor, Melbourne Health
-
Extraordinary Senior Lecture in the Department of Global Health, Stellenbosch University
-
Honorary Research Associate, Centre for Infectious Disease Epidemiology and Research, University of Cape Town
-
Professor; Director Sydney ID, University of Sydney
-
Faculty Member, Africa Health Research Institute; Wellcome Trust Senior Research Fellow, UCL
-
Associate Professor, Pharmaceutical Sciences, University of the Western Cape
-
Extraordinary Professor, Global Health, Stellenbosch University; South African Medical Research Council
-
Associate Professor of Biomedical Engineering, University of Michigan
-
Associate Professor, SARChI Research Chair in Mycobactomics, Stellenbosch University
-
Head of the Division of Pulmonology, University of Cape Town